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INTRODUCTION 
The concept of drug delivery has been revolutionized 
with the advancement in drug delivery systems, 
especially those offering a sustained and controlled 
action of drug to desired area of effect. These novel drug 
delivery system are capable of controlling the rate of 
drug delivery, sustaining the duration of therapeutic 
action, and/or targeting the delivery of drug to a specific 
site
1
. 
A well designed controlled drug delivery system offer 
several potential advantages over traditional method of 
administration such as:- 1. Drug release rates can be 
tailored to the needs of specific application, for ex- 
providing a constant rate of drug delivery or pulsatile 
release, 2. Controlled release systems provide protection 
of drugs, especially proteins that are otherwise rapidly 
destroyed by the body, 3. Controlled release system can 
increase patient comfort and compliance by replacing 
frequent (e.g. daily) doses with infrequent (once per 
month or less) injection.
1 
Microspheres as drug carriers are one of the most 
effective novel approach in sustaining and controlling 
the action of drug to a specific site (e.g tissue). They are 
characteristically free flowing powders of spherical 
shape, consisting of proteins or synthetic polymers, 
which are either biodegradable or non-biodegradable in 
nature and ideally having a particle size ranging from 1 
– 1000 μm. There are two types of microspheres: 
microcapsules and micromatrices, which are described 
as, microcapsules are those in which entrapped 
substances is distinctly surrounded by distinct capsule 
wall whereas in micromatrices the entrapped substance 
is dispersed or dissolved through the particle matrix, 
having the potential for the controlled release of drug. 
They are made up of polymeric, waxy, or other 
protective materials i.e biodegradable synthetic 
polymers and modified natural products.
2 
TYPES OF POLYMER
 
A number of different substances, both biodegradable as 
well as non-biodegradable have been investigated for 
the preparation of microspheres
3
. These materials 
include the polymers which are classified into two 
categories:- 
1. Synthetic polymers 
2. Natural polymers 
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1. Synthetic polymers: They are employed as carrier 
materials and are divided into two types:- 
(A) Non-biodegradable polymers: for ex- Poly methyl 
methacrylate, Acrolein, Glycidyl methacrylate, 
Epoxy polymers.
3
 
(B) Biodegradable polymers: for ex- Lactides and 
Glycolides and their copolymers, Poly alkyl cyano 
acrylates, Poly anhydrides and Poly-Є-
caprolactone(PCL).
3
 
2. Natural polymers: They are obtained from 
different sources like proteins, carbohydrates, and 
chemically modified carbohydrates.
3
 
(A) Proteins- Albumin, Gelatin, Collagen. 
(B) Carbohydrates- Agarose, Gelatin, Starch, Chitosan, 
Carrageenan. 
(C) Chemically modified carbohydrates- Poly(acryl) 
dextran, Poly(acryl) starch, DEAE cellulose. 
IDEAL MICROPARTICULATE CARRIERS
 
The material utilized for the preparation of 
microparticulates should have the following 
properties
3,4
:- 
 Longer duration of action. 
 Provide protection of drug. 
 Sterilizability. 
 Water solubility or dispersability. 
 Non-toxic. 
 Relative stability. 
 Bioresorbability. 
 Increase of therapeutic efficiency. 
 Control of content release. 
TYPES OF MICROSPHERES 
Bioadhesive microspheres
 
Adhesion is the sticking of drug to the membrane by 
using water soluble polymer which posses sticking 
property. Adhesion  of drug delivery device  to  the  
mucosal  membrane  such  as  buccal, ocular,  rectal,  
nasal  etc  can  be  termed  as  bio adhesion.  These  
kinds  of  microspheres  exhibit  a prolonged  residence  
time  at  the  site  of  application and causes intimate 
contact with the absorption site and  produces  better  
therapeutic  action. Preparation  of bioadhesive  
microspheres  would be advantageous to have  means 
for providing an  intimate  contact  of  the  drug  
delivery  system  with  the  absorbing  membranes  
.Polycarbophil (Noveon® AA1) selected as polymer in 
the production of bioadhesive microspheres due to its 
excellent bioadhesive properties.
5-9
  
Magnetic microspheres
 
This kind of delivery system is very much important 
which localizes the drug to disease site. In this larger 
amount of freely circulating drug can be replaced by 
smaller amount of magnetically targeted  drug. 
Magnetic  carriers receive magnetic responses  to  a  
magnetic  field  from  incorporated materials  that  are  
used  for magnetic  microspheres. Magnetic 
microspheres are prepared by mixing water soluble 
drugs(for lipophilic drugs, along with the dispersing 
agents) and 10nm magnetite(Fe3O4) particles in an 
aqueous solvent of matrix material. This mixture is 
then emulsified in the oil. Ultrasonication or shearing is 
done to produce particle of suitable size range. The 
matrix is then stabilized by chemical cross linking or 
heating.
3,8
 
Floating microspheres
 
In floating types the bulk density is less than the gastric  
fluid  and  so  remains  buoyant  in  stomach without 
affecting gastric emptying rate. The drug is released 
slowly  at the desired rate, if the  system is floating  on  
gasteric  contentand,  increases  gastric residence  and  
increases  fluctuation  in  plasma concentration. This 
system produces prolonged therapeutic effect and 
therefore reduces dosing frequencies. On  each  
subsequent  gastric  emptying,  sink particles will 
spread out over a large area of absorption sites, 
increasing the opportunity for  drug release  profile  and  
absorption  in  a  more  or  less  predictable  way.  
Moreover,  since  each  dose consists of many subunits, 
the risk of dose dumping is reduced.
9-11
 
Radioactive microspheres
 
Radio     emobilisation      therapy      microspheres 
sized 10-30  nm  are  of  larger  than  capillaries  and  
gets tapped  in  first  capillary  bed  when  they  come 
across. They are injected to the arteries that lead to 
tumour  of  interest.  So in all  these  conditions 
radcioactive  microspheres  deliver  high  radiation dose  
to  the  targeted  areas  without  damaging  the normal  
surrounding  tissues. Different kinds of  radioactive  
microsphers  are  α  emitters,  β emitters, γ emitters. 3,12 
Polymeric microspheres 
The different types of polymeric microspheres can be 
classified on the basis of biodegradable and non-
biodegradable polymers into:- 
 Biodegradable polymeric microspheres 
Natural polymers such as starch are used because of 
their biodegradable, biocompatible, bio adhesive 
property. Biodegradable polymers prolongs the 
residence time when comes in contact with mucous 
membrane due to its high degree of swelling property 
with aqueous medium which results in formation of 
gel. Concentration of polymers controls the release of 
drug.
13 
 Synthetic polymeric microspheres 
Synthetic polymeric microspheres are widely  used  in  
clinical application, but the main disadvantage of these 
kind  of  microspheres,  are  tend  to  migrate  away 
from  injection  site  and  lead  to  potential  risk, 
embolism and further organ damage.
14 
METHOD OF PREPARATION
 
The preparation of microspheres should satisfy certain 
criteria.
 15
 They are:  
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 (i) The ability to incorporate  reasonably 
concentrations of the drug,  
(ii)Stability of  the  preparation  after  synthesis with a 
clinically acceptable shelf-life,  
(iii) Controllable particle size and dispensability in 
aqueous vehicles for injection,  
(iv)Release  of  active  agent  with  good  control over a 
wide time scale,  
(v) Biocompatibility  with  a  controllable 
biodegradability, and   
(vi)Susceptibility to chemical modification. 
Techniques for microsphere preparation 
The techniques are as follows
3,16
   
1. Single emulsion techniques 
2.  Double emulsion techniques  
3.  Polymerization  
  a. Normal polymerization  
       i.  Bulk  
         ii.  Suspension  
                  iii.  Emulsion  
         b. Inter-facial polymerization  
4.  Phase separation coacervation technique  
5.  Spray drying and spray congealing 
6.  Solvent extraction 
7.  Quassi emulsion solvent diffusion 
Single emulsion techniques  
There are several natural polymers for ex- 
carbohydrates and proteins that act as microparticulate 
carriers and are prepared by single emulsion technique. 
In which the natural polymers are dissolved or 
dispersed in the non-aqueous medium e.g. oil. In next 
step, cross linking is carried out by either of two 
following methods-
17-20
 
i. Cross linking by heat: cross linking by heat is 
carried out by adding the dispersion, to previously 
heated oil. Heat denaturation is however, not 
suitable for the thermolabile drugs.
 17-20
 
ii. Chemical cross linking: chemical cross liking is 
done with the help of agents such as glutraldehyde, 
formaldehyde, terephthaloyl chloride, diacid 
chloride, etc. This method suffers from 
disadvantage of excessive exposure of active 
ingredients to chemicals if added at the time of 
preparation, chitosan solution(in acetic acid) by 
adding to liuid paraffin containing a surfactant 
resulting in the formation of w/o emulsion.
 
 
Metformin hydrochloride microsphere are prepared 
by using glutraldehyde 25% solution as a cross 
limking agent. (figure-1).
 17-20
 
 
 
Figure 1: Processing scheme for microspheres-preparation by single emulsion technique
15 
 
Double emulsion techniques
 
Involves  the  formation  of  the  multiple  emulsions  or  
the double  emulsion  of type  w/o/w  and  is  best  
suited  to  the water-soluble  drugs,  peptides,  proteins  
and  the  vaccines. This method can be used with both 
the natural as well as the synthetic polymers.  The  
aqueous  protein  solution  is dispersed  in  a  lipophilic  
organic  continuous  phase.  This protein solution may 
contain the active constituents. The continuous  phase  
is  generally  consisted  of  the  polymer solution  that  
eventually  encapsulates  of  the  protein contained  in  
dispersed  aqueous  phase.  The  primary emulsion is  
then  subjected  to  the  homogenization  or  the 
sonication before addition to the aqueous solution of 
the polyvinyl  alcohol  (PVA).  This results  in  the  
formation  of the  double  emulsion.  The  emulsion  is  
then  subjected  to the  solvent  removal  either  by  
solvent  evaporation  or  by solvent  extraction  process.  
The  solvent  evaporation  is carried  out  by 
maintaining  emulsion  at  reduced  pressure or  by  
stirring  the  emulsion  so  that  the  organic  phase 
evaporates  out.  In  the  latter  case,  the emulsion  is  
added to the large quantity of water (with or without 
surfactant) into  which  organic  phase  diffuses  out.  
The  solid microspheres are subsequently obtained by 
filtration and washing.  A  number  of  hydrophilic  
drugs  like  luteinizing hormone releasing  hormone  
(LH-RH)  agonist;  vaccines, proteins/peptides  and  
conventional  molecule  are successfully incorporated 
in to the microspheres using the method  of  double  
emulsion  solvent evaporation/extraction.
 3,20,21
figure-2) 
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Figure 2: Processing scheme for microspheres-preparation by double emulsion technique
15
 
Polymerization technique
 
The  polymerization  techniques  used  for  the  
preparation  of the microspheres are mainly classified 
as
16
:  
 Normal polymerization  
 Interfacial polymerization 
 Normal polymerization 
1) Bulk polymerization:  
A monomer or a mixture of monomer along with the 
initiator is usually heated  to  initiate  the  
polymerization  and  carry out the process. The catalyst 
or the initiator is added to the reaction mixture  to  
facilitate  or  accelerate  the  rate  of  the reaction.  The 
polymer  so  obtained  may  be  molded  or fragmented 
as microspheres. For loading of drug, adsorptive drug 
loading  or  adding  drug  during  the  process  of 
polymerization may be adopted.
 16
   
2) The suspension polymerization:  
It  is  carried  out  by  heating  the  monomer  or  
mixture  of monomers  with  active  principles  (drugs)  
as  droplets dispersion in a continuous aqueous phase. 
The droplets may also contain an initiator and other 
additives.
 16
   
3) The emulsion polymerization:  
 However, differs  from  the  suspension polymerization  
as due to  presence  of  the  initiator  in  the  aqueous  
phase,  which later  on  diffuses  to  the  surface  of  the  
micelles  or  the emulsion globules.
 16
  
 Interfacial polymerization  
In  Interfacial  polymerization  technique  two  reacting 
monomers  are  employed;  one  of  which is  dissolved 
in the continuous   phase  w hi l e   the  other  being  
dispersed  in the  continuous  phase.  The  continuous  
phase  is  generally aqueous in nature through which 
the second monomer is emulsified. The monomers 
present in either phase diffuse rapidly  and  polymerize  
rapidly  at  the  interface.  Two conditions  arise  
depending  upon  the  solubility  of  formed polymer in 
the emulsion droplet. If the polymer is soluble in  the  
droplet  it  will  lead  to  the  formation  of  the 
monolithic  type  of  the  carrier  on  the hand if  the  
polymer is insoluble in the monomer droplet, the 
formed carrier is of capsular (reservoir) type. The  
degree  of  polymerization  can  be  controlled  by  the 
reactivity  of  the  monomer  chosen,  their  
concentration,and the composition of the vehicle of 
either phases and by the temperature of the system. 
Controlling the droplets or globules  size  of  the  
dispersed  phase  can  control  the particle  size.  The  
polymerization  reaction  can  be controlled  by  
maintaining  the  concentration  of  the monomers,  
which  can  be  achieved  by  addition  of  an excess  of  
the  continuous  phase.
 16
 (figure-3)
   
 
Figure 3: Polymerization method
15 
Phase separation coacervation technique 
Specially  designed  for  preparing  the  reservoir type  
of  the  system,  i.e.,  to  encapsulate  water soluble 
drugs e.g. peptides, proteins, matrix type particularly,  
when  the  drug  is  hydrophobic  in nature  e.g.,  
steroids.    In  matrix  type  device,  the drug  or  the  
protein  is  soluble  in  the  polymer phase.  The process 
is based on the principle of decreasing  the  solubility  of  
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the  polymer  in  the organic  phase  to  affect  the  
formation  of  the polymer rich phase called the 
coacervates.  The coacervation can be brought about by 
addition of the third component to the system which 
results in  the  formation  of  the  two  phases,  one  i.e. 
supernatant, depleted of the polymer.
 3,22
  
In this technique, the polymer is first dissolved in a  
suitable  solvent  &  then  drug  is  dispersed  by making  
its  aqueous  solution,  if  hydrophilic  or dissolved  in  t  
he  polymer  solution  itself,  if hydrophobic.  Phase 
separation is  then accomplished  by  changing  the  
solution conditions.
 3,22
 (figure-4) 
 
Figure 4: Coacervation phase separation method
15 
 
Spray drying and spray congealing
 
Concept of spray drying technique (fig 1) depending 
upon the removal of solvent or the cooling of solution 
the two processes  are  spray  drying  &  spray  
congealing. Evaporation  is  the  basic  mechanism  in  
spray  drying, whereas in spray congealing it is that of a 
phase inversion from a liquid to a solid. Both processes 
are similar, except for  energy  flow1.  Spray  drying  is  
the  most  widely  used industrial process involving 
particle formation and drying. Therefore, spray drying is 
an ideal process where the end-product  must  comply  
with  precise  quality  standards regarding  particle  size  
distribution,  residual  moisture content, bulk density, 
and particle shape.
 23,24,25
   
Principle: Three steps involved in spray drying : 
a.) Atomization: of a liquid feed change into fine 
droplets.   
b.)  Mixing:  it  involves  the  passing  of  hot  gas  
stream through  spray  droplets  which  result  in  
evaporation  of liquids and leaving behind dried 
particles.  
c.)  Dry:  Dried powder  is  separated  from  the  gas  
stream and collected.  
In  this  technique  polymer  is  first  dissolved  in  a  
suitable volatile  organic  solvent  such  as  
dichloromethane, acetone, etc. The drug in the solid 
form is then dispersed in  the  polymer  solution  under  
high-speed homogenization.  This  dispersion  is  then  
atomized  in  a stream of hot air, this form small droplets 
or the fine mist, from  which  the  solvent  evaporates  
instantaneously leading the formation of the 
microspheres. The size range is 1-100 µm. By using hot 
air separate of Microparticle by means  of  the  cyclone  
separator  while  the  traces  of solvent are removed by 
vacuum drying. Advantages of the process are 
feasibility of operation. This technique is very useful  to  
encapsulate  various  penicillins.  Thiamine mononitrate  
and  sulpha  ethylthiadizole  are encapsulated  in  a  
mixture  of  mono-  and  diglycerides  of stearic acid and 
palmitic acid using spray congealing. Very rapid  
solvent  evaporation,  however  leads  to  the formation 
of porous microparticles. The sprays are produces by 
either rotary (wheel) or nozzle atomizers. Evaporation of 
moisture from the droplets and formation  of  dry  
particles  proceed  under  controlled temperature and 
airflow conditions.  The microsphere size is controlled 
by the rate of spraying, nozzle  size,  temperature  (in  
drying  and  collecting chambers.)  and  the  feed  rate  
of  polymer  drug  solution. The quality of product is 
improved by addition plasticizer spray flow rate should 
kept constant around 6ml/min
2
 .Spray  drying  technique  
is  also  useful for  preparing chitosan  microsphere,  In  
1999  He  et.al.  Used formaldehyde as a crosslinking 
and also reported a novel method  in  which  cimetidine  
and  famotidine  were entrapped  in  microspheres  
prepared  by  spray  drying  of multiple emulsion (o/w/o 
or w/o/w). They found that the release  of  the  drugs  
from  microspheres  by  this  novel method was 
significantly sustained as compared to those prepared  
by  conventional  spray  drying  or  o/w  emulsion 
method. In  1994  Giunchedi  et  al.  was  used  spray 
drying  used  for  the  preparation  of  PCL  
microspheres  of ketoprofen. He used the organic 
solution of the drug and two polymers, cellulose acetate 
butyrate and PCL was made  in  a  mixture  of  
dichloromethane  and  chloroform (1:1). The prepared 
solution was sprayed through a nozzle in  a  spray-drier  
under  different  experimental  conditions.  Solid  
microspheres  were  collected        into      final     
bottom    vessel    spray-drier.
 23-25
 
 
Figure 5: Spray drying and spray congealing
15 
Solvent extraction 
For  the  formation  of  the  emulsion  between  polymer 
solution  and  an  immiscible  continuous  phase  in  
aqueous (o/w) as well as non-aqueous phase (w/o) . 
Bogataj et  al.  (2000)  prepared  microsphere  by  using  
liquid paraffin/ acetone as the solvents by evaporation 
method. The  drug  solution  (in  acetone)  was  
dispersed  in  chitosan solution and this mixture was 
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emulsified in liquid paraffin and stirred. The suspension 
of microspheres was filtered, washed  and  dried.  
Magnesium  stearate  was  also  added for  preventing  
agglomeration  as  a  Agglomeration preventing  agent.  
The     results     showed  that  average particle  size  
decreased  with  increasing  amount  of magnesium  
stearate  used  for microsphere  preparation. Lim  et  al.  
(2000)  investigated  the  comparison  of mucoadhesive  
microspheres  of  hyaluronic  acid,  chitosan glutamate  
and  a  combination  of  the  two  prepared  by solvent 
evaporation with microcapsules of hyaluronic acid and 
gelatin prepared by complex coacervation.
 20,21
 
Quassi emulsion solvent diffusion 
A  novel  quasi-emulsion  solvent  diffusion  method  to 
prepare  the  controlled  release  microspheres  of  drugs 
with acrylic polymers has been reported in the literature. 
Microsponges  can  be  prepared  by  a  quasi-emulsion 
solvent  diffusion  method  using  an  external  phase 
containing distilled water and polyvinyl alcohol (PVA). 
The internal  phase  is  consisting  of  drug,  ethyl  
alcohol  and polymer is added at an amount of 20% of 
the polymer in order to   facilitate  the  plasticity.  At  
first,  the  internal phase is  prepared  at  60ºC  and  
added  to  the  external  phase  at room  temperature.  
After  emulsification,  the  mixture  is continuously 
stirred for 2 hours. Then the mixture can be filtered  to  
separate  the  microsponges.  The  product  is then  
washed  and  dried  by  vacuum  oven  at  40ºC  for  24 
hours. Example: - Ibuprofen.
 16
 
EVALUATION OF MICROSPHERES
 
Particle size and shape: 
The most widely used procedures to visualize 
microparticles are conventional light microscopy 
(LM)and scanning electron microscopy (SEM). Both 
can beused to determine the shape and outer structure of 
microparticles. LM provides a control over coating 
parameters in case of double walled microspheres. The 
microspheres structures can be visualized before and 
after coating and the change can be measured 
microscopically. SEM provides higher resolution in 
contrast to the LM. SEM allows investigations of the 
microspheres surfaces and after particles are cross-
sectioned, it can also be used for the investigation of 
double walled systems.  Conflocal fluorescence 
microscopy is used for the structure characterization of 
multiple walled microspheres. Laser light scattering and 
multi size coulter counter other than instrumental 
methods, which can be used for the characterization of 
size, shape andmorphology of the microspheres.
 3,17,26-29
 
Electron spectroscopy for chemical analysis: 
The surface chemistry of the microspheres can be 
determined using the electron spectroscopy for chemical 
analysis (ESCA). ESCA provides a means for the 
determination of the atomic composition of the surface. 
The spectra obtained using ECSA can be used to 
determine the surfacial degradation of the biodegradable 
microspheres.
 3,17,26-29
 
Attenuated total reflectance Fourier Transfom-
Infrared Spectroscopy: 
FT-IR is used to determine the degradation of the 
polymeric matrix of the carrier system. The surface of 
the microspheres is investigated measuring alternated 
total reflectance (ATR). The IR beam passing through 
the ATR cell reflected many times through the sample to 
provide IR spectra mainly of surface material. The 
ATR-FTIR provides information about the surface 
composition of the microspheres depending upon 
manufacturing procedures and conditions.
 3,17,26-29
 
Density determination: 
The density of the microspheres can be measured by 
using a multi volume pychnometer. Accurately weighed 
sample in a cup is placed into the multi volume 
pychnometer. Helium is introduced at a constant 
pressure in the chamber and allowed to expand. This 
expansion results in a decrease in pressure within the 
chamber. Two consecutive readings of reduction in 
pressure at different initial pressure are noted. From two 
pressure readings the volume and hence the density of 
the microsphere carrier is determined.
 3,17,26-29
 
Isoelectric point: 
The micro electrophoresis is an apparatus used to 
measure the electrophoretic mobility of microspheres 
from which the isoelectric point can be determined. The 
mean velocity at different Ph values ranging from 3-10 
is calculated by measuring the time of particle 
movement over a distance of 1 mm. By using this data 
the electrical mobility of the particle can be determined. 
The electrophoretic mobility can be related to surface 
contained charge, ionisable behaviour or ion absorption 
nature of the microspheres.
 3,17,26-29
 
Surface carboxylic acid residue: 
The surface carboxylic acid residue is measured by 
using radioactive glycine. The radioactive glycine 
conjugates is prepared by the reaction of c14-glycine 
ethyl ester hydro chloride with the microspheres. The 
glycine residue is linked using the water soluble 
condensing 1-ethyl-3 (3 dimethyl amino propyl) 
carbidiimide (EDAC). The radioactivity of the conjugate 
is then measured using liquid scintillation counter. Thus 
the carboxylic acid residue can be compared and 
correlated. The free carboxylic acid residue can be 
measured for hydrophobic or hydrophilic or any other 
derivatized type of the microspheres.
 3,17,26-29
 
Surface amino acid residue: 
Surface associated amino acid residue is determined by 
the radioactive c14-acetic acid conjugate. The 
carboxylic acid residue is measured through the liquid 
scintillation counter and hence the amino acid residue 
can be determined indirectly. EDAC is used to condense 
the amino group and the c14 –acetic acid carboxylic 
acid residue. The method used for determining the free 
amino or the free carboxylic acid residues are based on 
indirect estimation, by measuring the radioactivity of the 
c14 having acetic acid or the glycine conjugate. The 
accuracy of the method however, depends on the time 
allowed for conjugation of the radioactive moiety and 
the reactivity of free functional group.
 3,17,26-29
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Capture efficiency: 
The capture efficiency of the microspheres or the 
percent entrapment can be determined by allowing 
washed microspheres to lyse. The lysate is then 
subjected to the determination of active constituents as 
per monograph requirement.
 3,17,26-29
 The percent 
encapsulation efficiency is calculated using following 
equation: 
% Entrapment = Actual content/Theoretical content x 100 
Angle of contact: 
The angle of contact is measured to determine the 
wetting property of a micro particulate carrier. It 
determines the nature of microspheres in terms of 
hydrophilicity or hydrophobicity. This thermodynamic 
property is specific to solid and affected by the presence 
of the adsorbed component. The angle of contact is 
measured at the solid/air/water interface. The advancing 
and receding angle of contact are measured by placing a 
droplet in a circular cell mounted above objective of 
inverted microscope. Contact angle is measured at 20
0
C 
within a minute of deposition of microspheres.
 3,17,26-29
 
In vitro methods: 
There is a need for experimental methods which allow 
the release characteristics and permeability of a drug 
through membrane to be determined. For this purpose, a 
number of in vitro and in vivo techniques have been 
reported. In vitro drug release studies have been 
employed as a quality control procedure in 
pharmaceutical production, in product development etc. 
Sensitive and reproducible release data derived from 
physico chemically and hydro dynamically defined 
conditions are necessary. The influence of 
technologically defined conditions and difficulty in 
simulating in vivo conditions has led to development of 
a number of in vitro release methods for buccal 
formulations; however no standard in vitro method has 
yet been developed. Different workers have used 
apparatus of varying designs and under varying 
conditions, depending on the shape and application of 
the dosage form developed.
 3,17,26-29
  
In vivo methods: 
Methods for studying the permeability of intact mucosa 
comprise of techniques that exploit the biological 
response of the organism locally or systemically and 
those that involve direct local measurement of uptake or 
accumulation of penetrants at the surface. Some of the 
earliest and simple studies of mucosal permeability 
utilized the systemic pharmacological effects produced 
by drugs after application to the oral mucosa. However 
the most widely used methods include in vivo studies 
using animal models, buccal absorption tests, and 
perfusion chambers for studying drug permeability.
 
3,17,26-29
 
IN-VITRO-IN-VIVO CORRELATIONS 
Correlations between in vitro dissolution rates and the 
rate and extent of availability as determined by blood 
concentration and or urinary excretion of drug or 
metabolites are referred to as “in vitro-in vivo 
correlations”. Such correlations allow one to develop 
product specifications with bioavailability.
 30,31
 
Percent of Drug Dissolved In Vitro Vs Peak Plasma 
Concentration 
One of the ways of checking the in vitro and in vivo 
correlation is to measure the percent of the drug released 
from different dosage forms and also to estimate the 
peak plasma concentrations achieved by them and then 
to check the correlation between them. It is expected 
that a poorly formulated dosage form releases amount of 
drug than a well formulated dosage form, and, hence the 
amount of drug available for absorption is less for 
poorly formulated dosage form than from a well 
formulated dosage form.
 30,31
 
Percent of Drug Dissolved Vs Percent of Drug 
Absorbed 
If the dissolution rate is the limiting step in the 
absorption of the drug, and is absorbed completely after 
dissolution, a linear correlation may be obtained by 
comparing the percent of the drug absorbed to the 
percent of the drug dissolved. If the rate limiting step in 
the bioavailability of the drug is the rate of absorption of 
the drug, a change in the dissolution rate may not be 
reflected in a change in the rate and the extent of drug 
absorption from the dosage form.
 30,31
 
Dissolution Rate Vs Absorption Rate 
The absorption rate is usually more difficult to 
determine than the absorption time. Since the absorption 
rate and absorption time of a drug are inversely 
correlated, the absorption time may be used in 
correlating the dissolution data to the absorption data. In 
the analysis of in vitro and in vivo drug correlation, 
rapid drug absorption may be distinguished from the 
slower drug absorption by observation of the absorption 
time for the dosage form. The quicker the absorption of 
the drug the less is the absorption time required for the 
absorption of the certain amount of the drug. The time 
required for the absorption of the same amount of   drug   
from the   dosage form is   correlated.
 30,31
 
Percent of Drug Dissolved Vs Serum Drug 
Concentration 
For drugs whose absorption from GIT is dissolution rate 
limited, a linear correlation may be established between 
the percent of drug dissolved at specified times and the 
serum drug concentrations at corresponding times.
 30,31
 
Percent of Drug Dissolved Vs Percent of the Dose 
Excreted in urine 
The percent of a drug dissolved and the percent of drug 
absorbed are linearly correlated. There exists a 
correlation between the amount of drug in body and the 
amount of drug excreted in the urine. Therefore, a linear 
relation may be established between the percent of the 
drug dissolved and the percent of the dose excreted in 
the urine.
 30,31
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APPLICATIONS
 
1 Microspheres in vaccine delivery 
The prerequisite of a vaccine is protection against the 
micro organism or its toxic product. An ideal vaccine 
must fulfill the requirement of efficacy, safety, 
convenience in application and cost. The aspect of 
safety and minimization of adverse reaction is a 
complex issue48. The aspect of safety and the degree of 
the production of antibody responses are closely related 
to mode of application. Biodegradable delivery systems 
for vaccines that are given by parenteral route may 
overcome the shortcoming of the conventional 
vaccines.
3,32-36
 The interest in parenteral (subcutaneous, 
intramuscular, intradermal) carrier lies since they offer 
specific advantages including: 
i. Improved antigenicity by adjuvant action 
ii. Modulation of antigen release 
iii. Stabilization of antigen. 
2Targeting using microparticulate carriers 
The concept of targeting, i.e. site specific drug delivery 
is a well established dogma, which is gaining full 
attention. The therapeutic efficacy of the drug relies on 
its access and specific interaction with its candidate 
receptors. The ability to leave the pool in reproducible, 
efficient and specific manner is center to drug action 
mediated by use of a carrier system. Placement of the 
particles indiscrete anatomical compartment leads to 
their retention either because of the physical properties 
of the environment or biophysical interaction of the 
particles with the cellular content of the target tissue.
 3,32-
36
 
3 Monoclonal antibodies mediated microspheres 
targeting 
Monoclonal antibodies targeting microspheres are 
immunomicrospheres. This targeting is a method used to 
achieve sel ctive targeting to the specific sites. 
Monoclonal antibodies are extremely specific 
molecules. This extreme specificity of monoclonal 
antibodies (Mabs) can be utilized to target microspheres 
loaded bioactive molecules to selected sites. Mabs can 
be directly attached to the microspheres by means of 
covalent coupling. The free aldehyde groups, amino 
groups or hydroxyl groups on the surface of the 
microspheres can be linked to the antibodies.
 3,32-36
 The 
Mabs can be attached to microspheres by any of the 
following methods 
              i. Non specific adsorption 
              ii. Specific adsorption 
              iii. Direct coupling 
              iv. Coupling via reagents 
4 Chemoembolisation 
Chemoembolisation is an endovascular therapy, which 
involves the selective arterial embolisation of a tumour 
together with simultaneous or subsequent local delivery 
the chemotherapeutic agent. The theoretical advantage is 
that such embolisations will not only provide vascular 
occlusion but will bring about sustained therapeutic 
levels of chemotherapeutics in the areas of the tumour. 
Chemoembolisation is an extension of traditional 
percutaneous embolisation techniques.
 3,32-36
 
5 Imaging 
The microspheres have been extensively studied and 
used for the targeting purposes. Various cells, cell lines, 
tissues and organs can be imaged using radio labeled 
microspheres. The particle size range of microspheres is 
an important factor in determining the imaging of 
particular sites. The particles injected intravenously 
apart from the portal vein will become entrapped in the 
capillary bed of the lungs.
 3,32-36
 This phenomenon is 
exploited for the scintiographic imaging of the tumour 
masses in lungs using labeled human serum albumin 
microspheres. 
6 Topical porous microspheres 
Microsponges are porous microspheres having myriad 
of interconnected voids of particle size range 5-300 µm. 
These microsponges having capacity to entrap wide 
range of active ingredients such as emollients, 
fragrances, essential oils etc., are used as the topical 
carries system further, these porous microspheres with 
active ingredients can be incorporated into formulations 
such as creams, lotions and powders. Microsponges 
consist of non collapsible structures with porous surface 
through which active ingredients are released in a 
controlled manner.
 3,32-36
 
7 Surface modified microspheres 
Different approaches have been utilized to change the 
surface properties of carriers to protect them against 
phagocytic clearance and to alter their body distribution 
patterns .The adsorption of the poloxamer on the surface 
of the polystyrene, polyester or poly methyl 
methacrylate microspheres renders them more 
hydrophilic and hence decrease their MPS uptake.
 3,32-36
 
Protein microspheres covalently modified by PEG 
derivatives show decreased immunogenicity and 
clearance. The most studied surface modifiers are: 
                    i. Antibodies and their fragments 
                    ii. Proteins 
                    iii. Mono-, oligo- and polysaccharides 
                    iv. Chelating compounds  (EDTA, DTPA or 
                           Desferroxamine) 
                     v. Synthetic soluble polymers 
Such modifications are provided surface of 
microspheres inorder to achieve the targeting to the 
discrete organs and to avoid rapid clearance from the 
body. 
CONCLUSION 
Due to the recent advances in the technology of novel 
drug delivery system, the microsphere is becoming a 
widely accepted method for delivering therapeutic 
agents. Development in the polymer science has made it 
possible to synthesize different biodegradable and non-
biodegradable polymers which can be used for the 
preparation of microspheres with different 
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characteristics by using different available techniques. 
The foregoing shows that microsphere as drug carrier 
has great potentials, being able to use not only for 
delivering drugs but also as diagnostic tools. Although 
considerable research is needed to make easy-to-
manufacture microsphere based pharmaceutical 
products, which comply with quality control 
requirements, they are very attractive systems, 
considering their advantages leading to a rapid 
development in this field. 
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